<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Washington,
D.</B></FONT><B>C. 20549</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">Date of Report (Date of Earliest Event
Reported): September 17, 2021</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="font: 12pt/107% Calibri, Helvetica, Sans-Serif; width: 100%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Better For You Wellness, Inc.</B>&nbsp;</P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0.8pt 0 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt/107% Calibri, Helvetica, Sans-Serif; padding-right: 0.8pt; text-align: center"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(Exact name of registrant as specified in its charter)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 29%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 42%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 1%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 27%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><B>Nevada</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>000-56262</B>&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>00-0000000</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(state
    or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(Commission
    File Number)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(IRS
    Employer Identification Number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 47%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 10%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 43%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: top"><P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>1349 East Broad Street&nbsp;</B></P>
        <P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Columbus, OH</B></P></TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><B>43205</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(address
    of principal executive offices)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(zip
    code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 100%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT>

<P><B>+1 (614) 368-9898</B></P>
</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(registrant&rsquo;s
    telephone number, including area code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 100%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt">
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Former Entity Name: Fast Track Solutions,
        Inc.</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">(former
    name or former mailing address, if changed since last report)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">[ &nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 11.25pt 0 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
registered pursuant to Section 12(b) of the Act:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding: 0.25pt; width: 33%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding: 0.25pt; width: 34%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding: 0.25pt; width: 33%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name
    of each exchange on which<BR>
    registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">None</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">None</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 11.25pt 0 0pt; text-align: justify">Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect; 230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Emerging
growth company&nbsp;&nbsp;[X]&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 12pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange Act.&nbsp;&nbsp;[
&nbsp;&nbsp;]&nbsp;</FONT><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt"></FONT></P>







<HR SIZE="3" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: #A0A0A0">

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&ldquo;We&rdquo;, &ldquo;Us&rdquo;, &ldquo;The Issuer&rdquo;
and or &ldquo;the Company&rdquo; refer to Better For You Wellness, Inc., a Nevada Company.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0"><B>Item 1.01 Entry into a Definitive Material Agreement</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">On September 17, 2021, our Board of Directors unanimously
approved to enter into and consummate a &ldquo;Term Sheet&rdquo; with Williamsburg Venture Holdings LLC, a Nevada limited liability
company (&ldquo;WVH&rdquo;). WVH is a multi-strategy, private investment fund located in New York. The Term Sheet is a private
placement with registration rights, providing WVH the ability to purchase up to $30,500,000 of our Common Stock. The term of the
Term Sheet is for 36 months. Following the execution of the term sheet, the Company is to pay WVH $15,000 to cover associated
expenses relating to, amongst other things, preparation of future securities agreements relating to the Term Sheet. Upon entering
into definitive agreements with WVH for the purchase and sale of equity, WVH is to immediately purchase $250,000 of the
Company&rsquo;s restricted common stock from the Company at a 15% discount to the last closing price of our Common Stock as reported
by the OTC Markets Group. Any future proceeds from the sale of shares, pursuant to the aforementioned term sheet, are to go towards
the Company to be used for working capital. Pursuant to the Term Sheet, WVH may not acquire, at any point, more than 4.99% of our
outstanding shares of common stock. </P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">On September 17, 2021, our Board of Directors unanimously
approved to enter into and consummate an agreement with SRAX, Inc., a Delaware Company (&ldquo;SRAX&rdquo;). Pursuant to the
agreement with SRAX, the Company will be granted access to a platform developed by SRAX, known as the &ldquo;Sequire Platform&rdquo;
which, amongst other things, will allow the Company to access trading data. According to SRAX, the platform is an investor
intelligence and communications management platform that allows users to &ldquo;unlock stock buyers' behaviors and trends for
issuers of publicly traded companies&rdquo;. In exchange for twelve months of access to the Sequire Platform, we paid SRAX $20,000.
Additional fees may be incurred as a result of this agreement, but we cannot accurately determine what they may be, although we
believe any such fees would be nominal.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Also on September 17, 2021, our Board of Directors unanimously
agreed to approve to enter into and consummate  another agreement with SRAX, whereas SRAX will provide advertising and marketing
services to the Company on a case by case basis, as may be requested by the Company.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">The above agreements with SRAX were entered into
pursuant to the normal course of business, in our opinion, and thus, we have not included the agreements as exhibits to this Form
8-K. A copy of the term sheet entered into with WVH is furnished as Exhibit 10.1 to this Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: left; text-indent: 0px">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On September 17, 2021, Mr. David H. Deming was appointed
Secretary of the Company&rsquo;s Board of Directors by the Company&rsquo;s Board of Directors.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biographical information of  Mr. David H. Deming is
below:</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
H. Deming</B></FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Deming, age 68, received a B.A. in Economics from Hobart College in 1975. Mr. Deming started his career at J.P. Morgan in 1976 and was
a Managing Director in charge of the Global Healthcare Investment Banking Group from 1991 to 2003.</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
April 2013 to March 2018, Mr. Deming served as Managing Partner at TAG Healthcare Advisors LLC, a boutique investment advisory firm.
From April 2015 to August 2018, Mr. Deming served as a director of Sorrento Therapeutics Inc., a clinical stage and commercial-stage
biopharmaceutical company that develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. Since
March 2018, David H. Deming has served as Partner and Chief Operating Officer of ID Fund LLC, an investor-directed firm for accredited
investors.</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships between Mr. Deming and any of the Company&#146;s directors or executive officers. It should be noted
however, that Mr. Deming is also a Director of the Company. There is no arrangement or understanding between Mr. Deming and any
other person pursuant to which Mr. Deming was appointed as the Secretary of the Board and there are no related party transactions
involving Mr. Deming that are reportable under Item 404(a) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>


<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01 Regulation FD Disclosure</B></FONT></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
September 21, 2021, we issued a pre</FONT>ss release relating to the information and events disclosed within
this Form 8-K. <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">A
copy of the Company&#146;s press release  is furnished as Exhibit 99.1 to this Report.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px"></P>

<P STYLE="color: rgb(0, 0, 0); font: 10pt Times New Roman, Times, Serif; margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; color: rgb(0, 0, 0); margin: 0; letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px">The
information in this Item 7.01, shall not be deemed to be &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any
filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as expressly set forth
by specific reference in such filing.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: rgb(0, 0, 0); letter-spacing: normal; word-spacing: 0px; text-align: justify; text-indent: 0px">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white"><B>Item 8.01 Other Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">On September 17, 2021, our Board
of Directors unanimously agreed to engage Carter Ledyard Milburn LLP as the Company&rsquo;s legal counsel going forward, to be
consulted on a case by case basis as may be necessary. Any future legal fees that may be incurred are to be billed hourly and may
not be static. We believe legal counsel to be important to the growth of the Company going forward.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">Currently, as of the filing
date of this report, the Company is still pending a FINRA corporate action to effectuate  a  name change from Fast
Track Solutions, Inc. to Better For You Wellness, Inc., and to change our ticker symbol. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="background-color: white">The legal date of our name
change, August 18, 2021, will differ from the market release date when posted on FINRA&rsquo;s daily list. An 8-K will be filed with
the Commission after completion of our corporate actions that will detail the new CUSIP number for our common stock and ticker
symbol.</FONT>&nbsp;</P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>ITEM
9.01. Financial Statements and Exhibits.</B></FONT></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)
Exhibits</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 11%; line-height: 107%; font-size: 12pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 89%; line-height: 107%; font-size: 12pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><U>NUMBER</U></FONT></TD>
    <TD STYLE="text-decoration: underline; padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><U>EXHIBIT</U></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt">10.1</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt">Term Sheet between Better For You Wellness, Inc. and Williamsburg Venture Holdings LLC</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">99.1</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Press Release</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<HR SIZE="3" NOSHADE ALIGN="CENTER" STYLE="width: 100%; color: #A0A0A0">

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the
undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 43%; line-height: 107%; font-size: 12pt">&nbsp;</TD>
    <TD STYLE="width: 57%; line-height: 107%; font-size: 12pt">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Better For You Wellness, Inc.</FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 11pt"></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif">Dated:
    &nbsp;September 21, 2021</FONT></TD>
    <TD STYLE="text-decoration: underline; padding-right: 0.8pt; line-height: 107%; font-size: 10pt"><FONT STYLE="font: 10pt/115% Times New Roman, Times, Serif"><U> <I>/s/
    Ian James </I></U></FONT></TD></TR>
<TR>
    <TD STYLE="padding-right: 0.8pt; line-height: 107%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.8pt">
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Ian James</P>
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>



</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8k92021.htm", "description": "8-K", "secsgml_size_bytes": 31695}]
{"company-data": {"conformed-name": "Fast Track Solutions, Inc.", "cik": "0001852707", "assigned-sic": "6770", "irs-number": "000000000", "state-of-incorporation": "NV", "fiscal-year-end": "0228"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-56262", "film-number": "211264861"}, "business-address": {"street1": "780 RESERVOIR AVENUE, #123", "city": "CRANSTON", "state": "RI", "zip": "02910", "phone": "401-440-9533"}, "mail-address": {"street1": "780 RESERVOIR AVENUE, #123", "city": "CRANSTON", "state": "RI", "zip": "02910"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.
C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event
Reported): September 17, 2021
Better For You Wellness, Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-56262
00-0000000
(state
    or other jurisdiction of incorporation)
(Commission
    File Number)
(IRS
    Employer Identification Number)
1349 East Broad Street
Columbus, OH
43205
(address
    of principal executive offices)
(zip
    code)
+1 (614) 368-9898
(registrant's
    telephone number, including area code)
Former Entity Name: Fast Track Solutions,
        Inc.
(former
    name or former mailing address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
[   ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
    of each class
Trading
    Symbol(s)
Name
    of each exchange on which
registered
None
None
None
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company  [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [
  ]
"We", "Us", "The Issuer"
and or "the Company" refer to Better For You Wellness, Inc., a Nevada Company.
Item 1.01 Entry into a Definitive Material Agreement
On September 17, 2021, our Board of Directors unanimously
approved to enter into and consummate a "Term Sheet" with Williamsburg Venture Holdings LLC, a Nevada limited liability
company ("WVH"). WVH is a multi-strategy, private investment fund located in New York. The Term Sheet is a private
placement with registration rights, providing WVH the ability to purchase up to $30,500,000 of our Common Stock. The term of the
Term Sheet is for 36 months. Following the execution of the term sheet, the Company is to pay WVH $15,000 to cover associated
expenses relating to, amongst other things, preparation of future securities agreements relating to the Term Sheet. Upon entering
into definitive agreements with WVH for the purchase and sale of equity, WVH is to immediately purchase $250,000 of the
Company's restricted common stock from the Company at a 15% discount to the last closing price of our Common Stock as reported
by the OTC Markets Group. Any future proceeds from the sale of shares, pursuant to the aforementioned term sheet, are to go towards
the Company to be used for working capital. Pursuant to the Term Sheet, WVH may not acquire, at any point, more than 4.99% of our
outstanding shares of common stock.
On September 17, 2021, our Board of Directors unanimously
approved to enter into and consummate an agreement with SRAX, Inc., a Delaware Company ("SRAX"). Pursuant to the
agreement with SRAX, the Company will be granted access to a platform developed by SRAX, known as the "Sequire Platform"
which, amongst other things, will allow the Company to access trading data. According to SRAX, the platform is an investor
intelligence and communications management platform that allows users to "unlock stock buyers' behaviors and trends for
issuers of publicly traded companies". In exchange for twelve months of access to the Sequire Platform, we paid SRAX $20,000.
Additional fees may be incurred as a result of this agreement, but we cannot accurately determine what they may be, although we
believe any such fees would be nominal.
Also on September 17, 2021, our Board of Directors unanimously
agreed to approve to enter into and consummate  another agreement with SRAX, whereas SRAX will provide advertising and marketing
services to the Company on a case by case basis, as may be requested by the Company.
The above agreements with SRAX were entered into
pursuant to the normal course of business, in our opinion, and thus, we have not included the agreements as exhibits to this Form
8-K. A copy of the term sheet entered into with WVH is furnished as Exhibit 10.1 to this Report.
Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain officers; Compensatory Arrangements of Certain Officers.
On September 17, 2021, Mr. David H. Deming was appointed
Secretary of the Company's Board of Directors by the Company's Board of Directors.
The
biographical information of  Mr. David H. Deming is
below:
David
H. Deming
Mr.
Deming, age 68, received a B.A. in Economics from Hobart College in 1975. Mr. Deming started his career at J.P. Morgan in 1976 and was
a Managing Director in charge of the Global Healthcare Investment Banking Group from 1991 to 2003.
From
April 2013 to March 2018, Mr. Deming served as Managing Partner at TAG Healthcare Advisors LLC, a boutique investment advisory firm.
From April 2015 to August 2018, Mr. Deming served as a director of Sorrento Therapeutics Inc., a clinical stage and commercial-stage
biopharmaceutical company that develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. Since
March 2018, David H. Deming has served as Partner and Chief Operating Officer of ID Fund LLC, an investor-directed firm for accredited
investors.
There
are no family relationships between Mr. Deming and any of the Company's directors or executive officers. It should be noted
however, that Mr. Deming is also a Director of the Company. There is no arrangement or understanding between Mr. Deming and any
other person pursuant to which Mr. Deming was appointed as the Secretary of the Board and there are no related party transactions
involving Mr. Deming that are reportable under Item 404(a) of Regulation S-K.
Item
7.01 Regulation FD Disclosure
On
September 21, 2021, we issued a pre
ss release relating to the information and events disclosed within
this Form 8-K.
A
copy of the Company's press release  is furnished as Exhibit 99.1 to this Report.
The
information in this Item 7.01, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any
filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except as expressly set forth
by specific reference in such filing.
Item 8.01 Other Events.
On September 17, 2021, our Board
of Directors unanimously agreed to engage Carter Ledyard Milburn LLP as the Company's legal counsel going forward, to be
consulted on a case by case basis as may be necessary. Any future legal fees that may be incurred are to be billed hourly and may
not be static. We believe legal counsel to be important to the growth of the Company going forward.
Currently, as of the filing
date of this report, the Company is still pending a FINRA corporate action to effectuate  a  name change from Fast
Track Solutions, Inc. to Better For You Wellness, Inc., and to change our ticker symbol.
The legal date of our name
change, August 18, 2021, will differ from the market release date when posted on FINRA's daily list. An 8-K will be filed with
the Commission after completion of our corporate actions that will detail the new CUSIP number for our common stock and ticker
symbol.
ITEM
9.01. Financial Statements and Exhibits.
(d)
Exhibits
NUMBER
EXHIBIT
10.1
Term Sheet between Better For You Wellness, Inc. and Williamsburg Venture Holdings LLC
99.1
Press Release
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Better For You Wellness, Inc.
Dated:
     September 21, 2021
/s/
    Ian James
Ian James
Chief Executive Officer